Among the industry-sponsored clinical trials initiated in Q1 2017, oncology trials dominated the field, followed by clinical trials for CNS.
Figure 1: oncology dominates industry-sponsored clinical trials in Q1 2017
Go deeper with GlobalData
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
Among these studies, there are more Phase I (241) studies than Phase II (234) and Phase III (193), accounting for 29%, 28% and 23% of the total clinical trials, respectively.
Figure 2: industry-sponsored clinical trials initiated in Q1 2017 by phase
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
Abbvie started the most clinical trials, followed by GSK in second place.
Figure 3: top sponsors for industry-sponsored clinical trials initiated in Q1 2017
Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]
